Veracyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. 

CEO
Marc A. Stapley
CEOMarc A. Stapley
Employees
824
Employees824
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2006
Founded2006
Employees
824
Employees824

VCYT Key Statistics

Market cap
2.29B
Market cap2.29B
Price-Earnings ratio
67.91
Price-Earnings ratio67.91
Dividend yield
Dividend yield
Average volume
1.29M
Average volume1.29M
High today
$29.45
High today$29.45
Low today
$28.11
Low today$28.11
Open price
$28.62
Open price$28.62
Volume
955.74K
Volume955.74K
52 Week high
$47.32
52 Week high$47.32
52 Week low
$19.73
52 Week low$19.73

VCYT News

Simply Wall St 7d
Veracyte, Inc. Just Beat EPS By 260%: Here's What Analysts Think Will Happen Next

As you might know, Veracyte, Inc. ( ) just kicked off its latest quarterly results with some very strong numbers. The company beat forecasts, with revenue of US...

Veracyte, Inc. Just Beat EPS By 260%: Here's What Analysts Think Will Happen Next

Analyst ratings

77%

of 13 ratings
Buy
76.9%
Hold
15.4%
Sell
7.7%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.